Agnathia-otocephaly complex in a fetus with maternal use of topical 1% salicylate.
Khan
Aneal
A
Department of Medical Genetics, University of Calgary, Alberta Children's Hospital, Calgary, Alberta Department of Pathology and Molecular Medicine Department of Obstetrics and Gynecology, McMaster University Medical Centre, McMaster University, Hamilton, Ontario, Canada.
Bourgeois
Jacqueline
J
Mohide
Patrick
P
D000014:Abnormalities, Drug-Induced; D004423:Ear / Q000002:abnormalities*; D005260:Female; D006801:Humans; D008297:Male; D008334:Mandible / Q000002:abnormalities*; D018811:Maternal Exposure; D011247:Pregnancy; D020156:Salicylic Acid / Q000009:adverse effects*; D050497:Stillbirth
D020156:Salicylic Acid